2001
DOI: 10.1006/fgbi.2001.1284
|View full text |Cite
|
Sign up to set email alerts
|

A Fungal Perspective on Human Inborn Errors of Metabolism: Alkaptonuria and Beyond

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
13
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 26 publications
1
13
0
Order By: Relevance
“…Intriguingly, whereas the two genes form a divergently oriented DNGP in several fungi (Fig. 1A), they do not show the same organization in the human genome (21). These results argue that amelioration of the deleterious effects of toxic ICs is a metabolic phenotype favored by selection in fungi as well as more generally across eukaryotes, resulting in DNGP formation.…”
Section: Phytophthora Infestansmentioning
confidence: 93%
See 2 more Smart Citations
“…Intriguingly, whereas the two genes form a divergently oriented DNGP in several fungi (Fig. 1A), they do not show the same organization in the human genome (21). These results argue that amelioration of the deleterious effects of toxic ICs is a metabolic phenotype favored by selection in fungi as well as more generally across eukaryotes, resulting in DNGP formation.…”
Section: Phytophthora Infestansmentioning
confidence: 93%
“…The human metabolic disease tyrosinemia also exists in multiple types that differ in severity, which are mimicked by the phenotypes of the corresponding gene knockouts in the model fungus Aspergillus nidulans (21). Tyrosinemia type I, the most severe, results from the loss of the final step in the pathway and the accumulation of the reactive, genotoxic compound fumarylacetoacetate, which increases the incidence of hepatic cancer (21). Similar to the Gal pathway, the genes of this metabolic pathway are also clustered in many fungal species, including A. nidulans (21) (Fig.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The genetic and biochemical interest in this pathway comes from the fact that many severe human diseases (e.g., phenylketonuria, alcaptonuria, tyrosinemia, tyrosinosis, Richner-Hanhart syndrome, and hawkinsinuria) are associated with enzyme deficiencies in the catabolism of Phe and Tyr (16,19,24,32,52,73). First, Phe is transformed into Tyr by a pterin-dependent phenylalanine hydroxylase (PhhA), and later, a tyrosine aminotransferase (TyrB) catalyzes the conversion of Tyr into 4-hydroxyphenylpyruvate (4-OH-PhPyr), which is further transformed into 2,5-OH-PhAc by a 4-OH-PhPyr dioxygenase (Hpd) (Fig.…”
mentioning
confidence: 99%
“…Taking its considerable metabolic versatility into consideration, Peñalva previously proposed to use the filamentous fungus Aspergillus nidulans as an alternative to animal models for certain aspects of human metabolic diseases (12). Accordingly, other authors have provided a large amount of data about deficiencies not only in the phenylalanine/Tyr pathway but also in the branched-chain amino acid pathways (4,5,13,14).…”
mentioning
confidence: 99%